Cytokinesis — Explain cytokinesis mechanisms and differences across cell types (conceptual)

The problem of how one cell becomes two has fascinated biologists since the earliest days of microscopy. While nuclear division—mitosis—was characterized in exquisite detail during the late nineteenth century, the physical partitioning of the cytoplasm received comparatively little attention. Researchers initially assumed that cytokinesis was merely a passive consequence of nuclear division, but accumulating evidence revealed that it involves an independent, tightly regulated molecular program. Understanding cytokinesis matters not only for basic cell biology but also for biomedicine: failures in cytokinesis produce multinucleated or polyploid cells, which are hallmarks of cancer progression, congenital cardiomyopathies, and certain developmental disorders.

This historical trajectory raises a central question: if all cells must ultimately partition their cytoplasm, why have evolution selected fundamentally different cytokinetic mechanisms across kingdoms of life? The answer lies in the physical constraints imposed by cell walls, cell size, and the geometry of the cytoskeleton—themes we will explore throughout this lesson.

Despite the diversity of cytokinetic strategies, several unifying principles govern how cells accomplish cytoplasmic division. First, cytokinesis must be spatially coordinated with the position of the mitotic spindle to ensure each daughter cell inherits one complete genome. Second, the process requires a mechanism for membrane remodeling—whether that involves constriction and fusion of the existing plasma membrane (as in animal cells) or de novo construction of an entirely new membrane partition (as in plant cells). Third, the final step of physical separation, called abscission, is subject to surveillance by checkpoint-like mechanisms that delay scission if chromatin bridges persist in the intercellular connection.

The following diagram illustrates the stages of animal cell cytokinesis, from specification of the cleavage plane through contractile ring assembly and constriction to final abscission. Pay close attention to how the central spindle positions the RhoA signaling zone and how the midbody forms as the intercellular bridge narrows.

As the diagram shows, the process begins with a signaling event, not a mechanical one. During anaphase, the centralspindlin complex—composed of MKLP1 (a kinesin-6 motor protein) and MgcRacGAP—accumulates at the spindle midzone. Centralspindlin recruits ECT2, a RhoGEF (guanine nucleotide exchange factor), which locally activates RhoA at the equatorial cortex. Active RhoA simultaneously stimulates formins (which nucleate unbranched actin filaments) and activates Rho-kinase (ROCK), which phosphorylates the regulatory light chain of myosin II. The result is a belt of antiparallel actin filaments interdigitated with bipolar myosin II minifilaments—the contractile ring. As myosin motors slide actin filaments past one another, the ring constricts, pulling the plasma membrane inward until only a narrow intercellular bridge remains. This bridge, stabilized by the midbody, is eventually severed by the ESCRT-III membrane scission complex in a step that typically occurs 1–3 hours after furrow ingression.

The signaling cascade that drives contractile ring assembly in animal cells can be described as a linear pathway with branching effectors. Understanding this pathway is essential because pharmacological or genetic disruption of any single node causes cytokinesis failure and the production of binucleate cells. The pathway initiates with spatial cues from the mitotic spindle and terminates in mechanical force generation at the cell cortex.

Signal Relay: From Spindle to Cortex

Two partially redundant signals specify the cleavage plane in animal cells. The central spindle pathway delivers a positive signal from the spindle midzone: centralspindlin concentrates ECT2 at the equator, promoting local RhoA activation. Simultaneously, the astral relaxation pathway operates through astral microtubules, which inhibit cortical contractility at the poles via Rac1 activation and local cortical relaxation factors. The net result is a narrow equatorial zone of high RhoA-GTP flanked by regions of low contractility—a spatial pattern that has been beautifully confirmed by FRET-based RhoA biosensors in living cells.

RhoA Effectors and Force Generation

Active RhoA-GTP binds at least three classes of effectors at the equatorial cortex. First, it activates the formin mDia2, which processively nucleates and elongates linear actin filaments—the structural backbone of the contractile ring. Second, RhoA activates ROCK (Rho-kinase), which phosphorylates the regulatory light chain (RLC) of myosin II, stimulating its ATPase activity and promoting assembly of myosin minifilaments. Third, RhoA activates citron kinase, which plays a role in maintaining the midbody during late cytokinesis. The contractile ring therefore represents a self-organized actomyosin structure whose constriction is powered by the same molecular motor (myosin II) used in muscle contraction, though the geometry and regulation differ substantially.

Abscission: The ESCRT-III Pathway

After furrow ingression is complete, the two daughter cells remain connected by a thin intercellular bridge (~1–2 µm in diameter) containing a dense structure called the midbody. The midbody serves as a signaling platform that recruits the ESCRT-III complex (endosomal sorting complexes required for transport). ESCRT-III subunits polymerize into helical filaments that constrict and sever the membrane, completing physical separation. Importantly, Aurora B kinase at the midbody acts as a sensor of chromatin bridges: if unsegregated chromatin traverses the intercellular bridge, Aurora B phosphorylates ESCRT-III regulatory subunits and delays abscission until the bridge is resolved—a surveillance mechanism known as the NoCut checkpoint.

The fundamental challenge of cytokinesis—physically dividing one cell into two—has been solved differently by animal cells, plant cells, fungi, and certain specialized cell types. These differences arise primarily from structural constraints: the presence or absence of a rigid cell wall, cell size, and the specific cytoskeletal toolkit available to each lineage. The following diagram and comparison table illustrate these divergent strategies.

Plant Cytokinesis in Detail: The Phragmoplast

In higher plants, cytokinesis begins during late anaphase with the assembly of the phragmoplast, a bipolar array of antiparallel microtubules and actin filaments that forms at the spindle midzone. Golgi-derived vesicles loaded with cell wall precursors (hemicelluloses, pectins) and membrane lipids are transported along phragmoplast microtubules toward the division plane, where they fuse to form a disc-like cell plate. The cell plate expands centrifugally—from the center outward—until it reaches the parental plasma membrane and cell wall, at which point the new membrane fuses with the existing plasma membrane, and the cell plate matures into a new segment of cell wall. This entire process is guided by the preprophase band (PPB), a transient ring of cortical microtubules and actin that forms before mitosis and marks the future division site on the cell cortex. Although the PPB disassembles before mitosis begins, its positional information persists as a cortical division zone that guides the expanding cell plate to the correct location.

The following worked example integrates the molecular details from earlier sections and asks you to reason through the consequences of specific perturbations—a common exam format in cell biology courses.

Our current understanding of cytokinesis is remarkably detailed for a few model systems—HeLa cells, C. elegans embryos, Drosophila S2 cells, and Arabidopsis root tips—but significant gaps remain, especially regarding how mechanical forces are integrated with biochemical signaling and how cytokinesis is regulated in tissues rather than isolated cultured cells.

Cytokinesis does not exist in isolation—it interfaces with chromosome segregation, cell polarity, tissue morphogenesis, and disease. Several advanced topics extend directly from the core mechanisms discussed in this lesson.

For students continuing to advanced cell biology or cancer biology, it is worth noting that cytokinesis is now recognized as a potential therapeutic target. Unlike mitotic poisons (e.g., taxol, vinca alkaloids) that target the spindle, drugs that selectively inhibit abscission could prevent the completion of cell division without affecting the spindle checkpoint—a strategy being explored for tumors resistant to conventional antimitotics. The ESCRT-III and Aurora B pathways are therefore of significant pharmacological interest.